Received 27 October 2012
aDepartment of Studies and Research in Chemistry, Tumkur University, Tumkur, Karnataka 572 103, India,bDepartment of Studies and Research in Chemistry, U.C.S., Tumkur University, Tumkur, Karnataka 572 103, India, and cDepartment of Studies and Research in Physics, U.C.S., Tumkur University, Tumkur, Karnataka 572 103, India
Correspondence e-mail: email@example.com
In the crystal of the title compound, C13H20N4, the molecule is nearly planar, the dihedral angles between the pyrimidine and the two pyrrolidine rings being 4.71 (2) and 4.50 (2)°. The crystal features inversion-related dimers linked by pairs of C-HN hydrogen bonds generating R22(16) patterns. The dimeric units are further linked into C(6) chains via an additional C-HN hydrogen bond.
For the synthesis and biological activity of pyrrolidine derivatives, see: Li et al. (2006); Lokhande et al. (2003); Imamura et al. (2004); Wyrzykiewicz, et al. (1993) and of pyrimidine derivatives, see: Holla et al. (2006); Zhao et al. (2007); Sondhi et al. (2005); Khalifa et al. (2005). For the graph-set description of hydrogen-bond motifs, see: Etter (1990); Bernstein et al. (1995).
Data collection: APEX2 (Bruker, 2009); cell refinement: APEX2 and SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 2012); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BV2214 ).
The authors thank Dr S. C. Sharma, Vice Chancellor, Tumkur University, Tumkur, for his constant encouragement, Professor T. N. Guru Row and Vijithkumar, S. S. C. U., Indian Institute of Science, Bangalore, for their help in collecting single-crystal data. The authors also thank Dr H. C. Devaraje Gowda, Department of Physics Yuvarajas College (constituent), University of Mysore, for his support.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
Bruker (2009). APEX2, SADABS and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Etter, M. C. (1990). Acc. Chem. Res. 23, 120-126.
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
Holla, B. S., Mahalinga, M., Karthikeyan, M. S., Akberali, P. M. & Shetty, N. S. (2006). Bioorg. Med. Chem. 14, 2040-2047.
Imamura, S., Ishihara, Y., Hattori, T., Kurasawa, O., Matsushita, Y. & Sugihara, Y. (2004). Chem. Pharm. Bull. 52, 63-73.
Khalifa, N. M., Ismail, N. S. & Abdulla, M. M. (2005). Egypt. Pharm. J. 4, 277-288.
Li, X., Li, Y. & Xu, W. (2006). Bioorg. Med. Chem. 14, 1287-1293.
Lokhande, T. N., Bobade, A. S. & Khadse, B. G. (2003). Indian Drugs, 40, 147-150.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Sondhi, S. M., Singh, N., Johar, M. & Kumar, A. (2005). Bioorg. Med. Chem. 13, 6158-6166.
Wyrzykiewicz, E., Bartkowiak, G. & Kedzia, B. (1993). Il Farmaco, 48, 979-988.
Zhao, X.-L., Zhao, Y.-F., Guo, S.-C., Song, H.-S., Wang, D. & Gong, P. (2007). Molecules, 12, 1136-1146.